1. Home
  2. NDLS vs CPIX Comparison

NDLS vs CPIX Comparison

Compare NDLS & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Noodles & Company

NDLS

Noodles & Company

N/A

Current Price

$0.72

Market Cap

29.8M

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$3.91

Market Cap

34.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NDLS
CPIX
Founded
1995
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.8M
34.1M
IPO Year
2013
2009

Fundamental Metrics

Financial Performance
Metric
NDLS
CPIX
Price
$0.72
$3.91
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
644.9K
148.6K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$494,087,000.00
$41,278,349.00
Revenue This Year
$2.18
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.21
52 Week Low
$0.55
$1.85
52 Week High
$1.74
$7.25

Technical Indicators

Market Signals
Indicator
NDLS
CPIX
Relative Strength Index (RSI) 37.10 80.29
Support Level $0.76 $2.42
Resistance Level $1.08 $2.73
Average True Range (ATR) 0.12 0.34
MACD -0.03 0.20
Stochastic Oscillator 0.48 91.45

Price Performance

Historical Comparison
NDLS
CPIX

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: